IceCure is engaged with leading medical institutions throughout the U.S. looking to participate in the post-market study with the FDA-cleared ProSense® Clinical study ...
IceCure's ICE3 study and the FDA Advisory Panel's favorable vote on ProSense® cryoablation's benefit-risk profile for low-risk breast cancer played a key ...
Cardiogen is a short regulatory peptide that has attracted sustained scientific curiosity within molecular biology and tissue signaling research. Classified among low–molecular–weight peptide ...
If you are trying to figure out whether Appian is attractively priced or not, you will want to see how its current share price stacks up against different measures of value. The stock closed at US$25.
The SEC has scrapped a civil case against the founder of BitClout. It comes one year after the Justice Department dismissed ...
Maintenance Chemotherapy in Patients With High-Risk Rhabdomyosarcoma: Long-Term Survival Analysis of the European Paediatric Soft Tissue Sarcoma Study Group RMS 2005 Trial Using data from the French ...
This workshop is designed to give nephrology teams the confidence they need to navigate complex regulatory requirements ...
The latest figures from the Department for Work and Pensions show over 3.9 million people across England and Wales are now receiving Personal Independence Payment (PIP), worth up to £749 a month for ...
Aetna has agreed to pay $117.7 million to resolve allegations that it violated the False Claims Act by submitting or failing to withdraw inaccurate diagnosis codes for its Medicare Advantage enrollees ...
DWP confirms new Universal Credit payment rates from April READ MORE: New PIP monthly payment rates for all eight award combinations from April Current payment rates. P ...
The kick-off signal for puberty begins in the brain. Specifically, in the hypothalamus, where specific neurons release a hormone that activates the hypophysis, at the base of the skull, which then ...
Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.